ArticleProceedings of the National Academy of Sciences of the United States of America2018
Contribution of NIH funding to new drug approvals 2010-2016.
Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
67 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Drug Costs in Federally Sponsored Cancer Clinical Trials: A Systematic Review.JAMA network open · 2026Pooled it
- Academic biomedical research is national defence.Nature reviews. Immunology · 2026Article
- Article
- Modeling the impacts of budget reductions at the U.S. NIH on research and innovation.npj health systems · 2026Article
- The rise of large language models and the direction and impact of US federal research funding.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- An evaluation of the US public-private Combating Antibiotic-Resistant Bacteria Accelerator (CARB-X) initiative.Health affairs scholar · 2026Article
- Article
- Analysis of National Institutes of Health funding for back pain research in the United States.North American Spine Society journal · 2026Article
- Ownership changes in the pharmaceutical industry: understanding the 2023 pharma mergers and acquisitions landscape of Europe.Journal of pharmaceutical policy and practice · 2026Article
- Spinal cord injury research and national institutes of health funding: a call to action.Spinal cord · 2026Article
- A thirty-year trend of increasing clinical orientation at the National Institutes of Health.bioRxiv : the preprint server for biology · 2025Article
- Beyond DALY: public funding of health innovation in Brazil as a political strategy for equity in the Global South.BMC public health · 2025Article
- Policies to promote affordability and access across the life cycle of costly new drugs.BMJ (Clinical research ed.) · 2025Article
- The potential of academic drug discovery: successes and challenges.Expert opinion on drug discovery · 2025Article
- Global distribution of research efforts, disease burden, and impact of US public funding withdrawal.Nature medicine · 2025Article
- The strength and importance of government-funded patents for approved drugs.Nature biotechnology · 2025Article
- NIH's 15% cap: a cost comparison and research outlook.EMBO reports · 2025Article
- Reforming the innovation system to deliver affordable medicines: a conceptual framework of pharmaceutical innovation as a complex adaptive system (forest) and theory of change.Journal of pharmaceutical policy and practice · 2025Article
- The origins of Novo Nordisk and Novartis products: piloting a framework to identify the public contributions.Journal of pharmaceutical policy and practice · 2025Article
- Government-Funded Health and Biomedical Research Is Irreplaceable.NAM perspectives · 2025Article
7 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This work examines the contribution of NIH funding to published research associated with 210 new molecular entities (NMEs) approved by the Food and Drug Administration from 2010-2016. We identified >2 million publications in PubMed related to the 210 NMEs (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.